|
Jun 30
|
5 Insightful Analyst Questions From Insulet’s Q1 Earnings Call
|
|
Jun 28
|
When Should You Buy Insulet Corporation (NASDAQ:PODD)?
|
|
Jun 25
|
Diabetes stocks rally after RFK comments on HHS campaign
|
|
Jun 24
|
How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?
|
|
Apr 17
|
4 Medical Product Stocks to Buy From a Challenging Industry
|
|
Feb 14
|
Stay Ahead of the Game With Insulet (PODD) Q4 Earnings: Wall Street's Insights on Key Metrics
|
|
Dec 31
|
GEHC vs. PODD: Which Stock Is the Better Value Option?
|
|
Dec 31
|
Insulet price target raised to $300 from $270 at BTIG
|
|
Dec 19
|
Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry
|